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reducing the expression of VEGF, TGFb1, TIMP1 and TIMP2 (p < 0.05).
After encapsulation in alginate for 1 or 30 days the cells were able to
differentiate in adipogenic and osteogenic lineage although after 30 days
in alginate beads these capacities were diminished.
Conclusion: MSCs maintain their immunomodulatory properties after
encapsulation in alginate beads even after 30 days, although their
differentiation capacities were reduced. These results support the
possibility of a safe and durable way of immune modulation in the
joint by introduction of MSCs encapsulated in alginate beads.
Fig. 1. MSCs gene expression of IL6 and IDO after cytokine stimulation in
monolayer, alginate beads after 48 hours preconditioning and alginate
beads after 30 days preconditioning cultures. BKI, best keeper index:
GAPDH, UBC, HPRT. ***p < 0.001; ****p < 0.0001.
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THE EXPRESSION OF TYPE2 COLLAGEN IS REGULATED BY PTEN IN
CHONDROCYTES
K. Iwasa, T. Nishiyama, S. Hayashi, T. Fujishiro, N. Kanzaki, K. Takebe,
K. Kawakita, R. Kuroda, M. Kurosaka. Kobe Univ. Graduate Sch., Kobe,
Japan
Purpose: Phosphatase and tensin homologue deleted on chromosome
10 (PTEN) was identiﬁed as an important tumor suppressor gene. PTEN
is second most frequently mutated gene in human cancer after p53. The
function of PTEN is one of negative regulator of phosphoinositol-3-kinase
(PI3K) signaling. PI3K pathway is critical for cell survival, differentiation
and matrix synthesis. We have reported that apoptosis by shear stress
in chondrocytes was dependent on p53, but the functions of PTEN in
chondrocytes are still unknown. Therefore, we investigated the function
of PTEN in chondrocytes.
Methods: NHAC-kn cells (normal human articular chondrocyte – knee)
were used for normal chondrocytes. Chondrocytes were cultured on
silicone chambers (STREX, Osaka, Japan), and stretched at 5% and 10%
stress for 24hours by pulse-motor-driven stretch machine (STREX, Osaka,
Japan). In order to inhibit the function of PTEN, PTEN siRNA was
transfected to NHAC-kn cells by lipofection method. After tranfection of
PTEN siRNA, NHAC-kn cells were applied 5% stretch stress for 24hours.
Further, chondrocytes were pretreated with PI3K speciﬁc inhibitor
(LY294002) and were applied at 5% stretch stress for 24hours.
The expressions of PTEN, p53 and type2 collagen (Col2) mRNA were
analyzed by real-time PCR. The expressions of Akt and phosphorylation
of Akt (pAkt) were analyzed by Western blotting.
Results: The expression levels of p53 were increased by stretch stress
in a stress dependent manner, but those of PTEN were not changed
(Figure 1). The expressions of Col2 were increased by 5% stretch stress,
but were decreased by 10% stretch stress (Figure 2).
After transfection of PTEN siRNA, the expressions of Col2 were increased
and were much more increased when 5% stretch stress was applied in
comparsion with control siRNA(Figure 3).
The expressions of pAkt were inceased after transfection of PTEN siRNA,
and were completely blocked by LY294002. The expressions of Col2 were
inhibited after exposure to LY294002.
Conclusions: PTEN is one of the most important tumor suppressor like
p53. We have reported that p53 was increased by shear stress, but
PTEN was not increased. The function of PTEN depends on its abundant
expression. However, p53 acts emergently when DNA is damaged. It
might be thought that the roles in chondrocytes were different between
PTEN and p53.
Zhang reported that Col2 expression was regulated via PI3K/Akt pathway.
We conﬁrmed that the expressions of Col2 were decreased with
attenuation of Akt phosphorylation when PI3K activity was blocked
by LY294002. Down-regulation of PTEN expression increased Col2
expression with activation of Akt phosphorylation. Therefore, PTEN
regulates the expressions of Col2 by inhibition of Akt phosphorylation.
In conclusion, PTEN might have an important role in cartilage repair by
regulation of Col2.
Fig. 1.
Fig. 2.
Fig. 3.
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ACID CERAMIDASE IMPROVES THE CHONDROGENIC PHENOTYPE OF
PRIMARY AND MESENCHYMAL STEM CELL-DERIVED CHONDROCYTES:
IMPLICATIONS FOR CARTILAGE REPAIR
C.M. Simonaro, S. Sachot, E. Eliyahu, H. Sun, E. Schuchman. Mount Sinai
Sch. of Med., NY, NY, USA
Background and Purpose: Acid ceramidase is a key regulatory enzyme
required to maintain the critical balance between the pro-apoptotic
signaling lipid, ceramide, and the pro-survival lipid, sphingosine-
1-phosphate (S1P). Several recent reports have demonstrated the
importance of this lipid-signaling pathway for normal cartilage
homeostasis, and abnormalities in this pathway have been associated
with several degenerative cartilage diseases. The purpose of this
study was therefore to evaluate the effects of human recombinant
acid ceramidase (rAC) on the growth and phenotype of primary and
mesenchymal stem cell (MSC)-derived chondrocytes, and its potential
use in cartilage repair.
Methods: Primary articular chondrocytes were grown with and without
rAC, and the expression of several chondrogenic markers were analyzed
by western blotting, immunohistochemistry, and/or qPCR. Safranin-O and
Alcian Blue staining also was performed. Similar studies were performed
using bone marrow cells, and the effects of rAC on the production and
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chondrogenic phenotype of the MSC was assessed following short-term
(1 week) culture.
Results: Addition of rAC to the culture media of rat articular chondrocytes
led to elevated expression of Sox-9, collagen IIA1, FGF2, TGF beta-1 and
several other chondrogenic markers. Similar results were obtained for
cells grown in monolayer cultures or 3-D collagen scaffolds. Elevated
Sox-9 and collagen IIA1 expression also was observed following rAC
treatment of human chondrocytes from a patient with osteoarthritis. No
changes in the total cell numbers were observed despite these positive
changes in the chondrogenic phenotype, indicating that the primary
effect of rAC was on the differentiation capacity of the cells, rather than
on cell survival. We also evaluated the effect of rAC on rat bone marrow
grown for 1 week, and found that the number of MSC in these cultures
was increased ~2–3-fold as assessed by colony forming units (CFU-F) and
ﬂow cytometry, and that their chondrogenic phenotype was positively
inﬂuenced as well.
Conclusions: Based on these results we suggest that AC is an important
enzyme required to maintain the differentiated phenotype of primary
chondrocytes, and that supplementation of media with rAC results in
improved chondrocyte quality following ex vivo expansion. rAC also
improves the yield of bone marrow-derived MSC from short-term
cultures, and their chondrogenic phenotype as well. rAC may therefore
be an important reagent that can be used to improve the production
of chondrocytes for cartilage repair, either ex vivo or through direct
administration to damaged cartilage sites.
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DETAILED EVALUATION OF CHONDRAL DEFECT REPAIR AND
AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL CELLS
TRANSPLANTATION. A NONHUMAN PRIMATE MODEL
S. Araki, S. Imai, M. Kubo, T. Mimura, K. Nishizawa, H. Ueba. Shiga Univ
of Med Sci., Otsu, Japan
Purpose: Articular cartilage injury remains one of the major concerns
in orthopaedic surgery. Although the repair process of articular cartilage
defects has been studied in many species. The extent and time course of
articular cartilage defect healing in humans are not well described.
Mesenchymal stem cells (MSCs) are an important cell source for cartilage
regeneration. A number of successful results in transplantation MSCs into
cartilage defects have been reported in animal models. However, Clinical
studies of MSCs transplantation for cartilage repair were very few.
Physicians not much know efﬁcacy and safety of MSCs transplantation
for cartilage repair in clinical.
Evaluation of the status of articular cartilage repair and MSCs
transplantation for articular cartilage repair at different time points in
a primate model may provide a healing process, efﬁcacy, safety and
postoperative activity recommendations in clinical.
Methods: Full-thickness osteochondral defects were created on the
medial femoral condyles(5mm in diameters and 5mm in depth) and
trochlea(3mm in diameters and 5mm in depth) of 18 cynomolgus
macaques, and the animals were divided into three groups: MSC, Gel,
and Defect. In the MSC group, the defects were ﬁlled with bone marrow-
derived MSCs embedded in collagen gel. In the Gel group, the defects
were ﬁlled with collagen gel without cells. In the Defect group, the
defects were left empty and additional defect were created on the lateral
femoral condyles(2mm in diameters and 5mm in depth). All groups were
evaluated by gross and histologic examination at 6-, 12- and 24-weeks.
Results: In the defect group, Cartilaginous repair responses failed to
occur in the lager 3mm defects, which was covered only by ﬁbrous scar
tissue. In contrast, hyaline-like articular cartilage was regenerated by
24 weeks in 2mm defects. In the MSC group, the border between bone
and cartilage moved upwards, integrations between native cartilage and
regenerated tissue were improved. After 24 weeks, histological scores
of the MSC group improved and were better than those of two other
control groups.
Conclusions: 2mm diameter full-thickness cartilage defect whose size
were critical for primate knees. In the primate animal model, signiﬁcant
improvements in the extent and quality of cartilage repair were observed
from the 12- to 24-week time points after transplantation of MSCs.
236
PROLIFERATIVE AND DIFFERENTIATION POTENTIAL OF STEM
CELLS DERIVED FROM THREE MESENCHYMAL TISSUES IN LATE STAGE
OSTEOARTHRITIC PATIENTS
L. Simion1, G. Shaw2, K. Mashayekhi2, P. Botez1, M. Murphy2, F. Barry2.
1Univ. Med. and Pharmacy, Iasi, Romania; 2REMEDI NUI, Galway, Ireland
Purpose: To asses the presence and biological potential of stem
cells in three mesehchymal tissues (subchondral bone, synovial layer,
periarticular adipose tissue) in late stages osteoarthritic patients, subjects
of total knee replacement (TKR)
Methods: Samples were collected from patients undergoing TKR, plastic
adherent cells cultured in complete aMEM with FGF b for succesive
passages: cell morphology and growth potential was recorded. Flow
cytometric surface cell markers detection for stemness antibodies
was performed. Differentiation assays for three mesenchymal lineages
(osteogenesis adipogenesis chondrogenesis) was assesed by qualitative
and quantitative method. Time lapse life cell imaging of nondiferentiated
cells over 24 hours period was used to determine cell kinetics.
Results: Mesenchymal cells derived from all donors and tissue types
displayed morphology and growth potential of MSCs, were positive
for stemness related antibodies (CD 105, CD 73, CD 90), underwent
differentiation toward three lineages with signiﬁcant differences
between tissue of origin and not between donors. Cell kinetics, recorded
for one donor, was different for adipose derived, synovial derived and
trabecular bone derived MSCs, a paralel could be made between growth
kinetics and recorded cell speed.
Conclusions: Late stage OA derived human tissues (subchondral
trabecular bone, extraarticular adipose tissue and synovial layer
contain phenotypically different MSCs which have different growth and
differentiation potential which could be related with the pathogeny
and progression of OA, further to be investigated; these tissues can be
conssidered as cell source for regenerative therapies.
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TGF-b TYPE II RECEPTOR AS A NOVEL INDICATOR OF CHONDROGENESIS
IN EQUINE BONE MARROW-DERIVED MESENCHYMAL STEM CELLS
K.K. Suter1, K.A. Payne1, V. Yao1, L.A. Fortier2, C.R. Chu1. 1Univ. of
Pittsburgh, Pittsburgh, PA, USA; 2Coll. of Vet. Med., Cornell Univ., Ithaca, NY,
USA
Purpose: Articular cartilage lacks the essential components for self-
repair, often resulting in inadequate healing of isolated cartilage
injury, which can lead to degenerative osteoarthritis (OA). Designing
techniques to improve cartilage repair after injury may prevent or
delay development of OA. Bone marrow-derived mesenchymal stem cells
(MSC) are a promising cell source for articular cartilage regeneration. In
vitro, MSC have been shown to undergo chondrogenic differentiation
in the presence of transforming growth factor b1 (TGF-b1), via a
signaling pathway known to play a key regulatory role in chondrogenesis.
Various knockout studies suggest that the TGF-b type II receptor
(TbR-II) is speciﬁcally important in skeletal muscle formation and
bone morphogenesis, but its role has not been clearly deﬁned in
chondrogenesis. The purpose of this study is to test the hypothesis
that levels of TbR-II can predict the cellular responsiveness of equine
bone marrow-derived MSC to TGF-b1 and are related to subsequent
chondrogenic potential.
Methods: Bone marrow aspirate was collected from the sternum of 9
horses and MSC were isolated and expanded in culture until passage
two. To evaluate chondrogenesis, equine MSC were cultured as pellets in
chondrogenic medium with or without addition of TGF-b1 (10ng/ml).
At Day 21, pellets were collected and pellet area was measured
using a stereomicroscope. Pellets were parafﬁn-embedded, sectioned
and stained with safranin-O/fast green for sulfated glycosaminoglycans
(GAG). The Bern score was used for histological grading with a
higher score indicating higher chondrogenesis. Presence of TbR-II was
analyzed by immunoﬂuorescence (K105, Cell Signaling Technology) and
ﬁve to seven regions of each pellet were imaged with ﬂuorescence
microscopy at 40X. The TbR-II intensity of each region was quantiﬁed
with Visiopharm image analysis software and normalized to the
number of cells. Comparisons between groups were performed using
paired t-tests and correlations were evaluated by Pearson’s correlation.
Statistical analysis was performed using SPSS and p< 0.05 was considered
signiﬁcant.
